Thank You for an Unforgettable Night
On November 19, survivors, physicians, friends, and supporters filled the Essex House for CR&T’s 2026 Cancer Survivors Hall of Fame Dinner. Together we celebrated two remarkable honorees, paid tribute to our founder, Dr. Richard T. Silver, and shared plenty of laughs along the way.
Congratulations to our 2026 honorees
Mindie Kaplan
Cancer Survivor Honoree
Founder, Million Mammogram Challenge
Rebecca Soffer
Richard T. Silver, MD Humanitarian Award
Cofounder, Modern Loss
To everyone who bought a ticket, hosted a table, placed a journal ad, or made a gift: thank you. Your generosity funds CR&T grants for cancer research.
Advancing Cancer Research
& Treatment for Patients
Around the Globe.
About the CR&T
Who We Are
In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer. While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 56-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.
BLOOD CANCER
RESEARCH
THE DR. RICHARD
T. SILVER CHAIR
FOR OTHER
CANCER RESEARCH











Medical Advisory Board
At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.